2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Oral Session

[O3] Oral Session 3　Hematologic Malignancies
【E】

Thu. Feb 17, 2022 9:30 AM - 10:50 AM Room 9 (Swan, 1F, Kyoto International Conference Center)

Chair：Koji Izutsu（Department of Hematology, National Cancer Center Hospital），Kinuko Mitani（Department of Hematology and Oncology, Dokkyo Medical University）
Discussant：Noriko Fukuhara（Tohoku University Hospital, Department of Hematology）

[O3-3] Subcutaneous Epcoritamab + R-CHOP in Previously Untreated High-Risk DLBCL: Preliminary Results From a Phase 1/2 Trial

○David Belada1, Jacob H. Christensen2, Kristina Drott3, Sylvia Snauwaert4, Joshua Brody5, Mayur Narkhede6, Fritz Offner7, Brian Elliott8, Tracy Liu8, Mariana Cota Stirner9, Aqeel Abbas8, Lorenzo Falchi10, Michael Roost Clausen11 (1.4th Department of Internal Medicine-Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic, 2.Odense University Hospital, Odense, Denmark, 3.Skane University Hospital, Scania, Sweden, 4.Department of Hematology, AZ Sint-Jan Hospital, Bruges, Belgium, 5.Icahn School of Medicine at Mount Sinai, New York, NY, USA, 6.O’Neal Comprehensive Cancer Center at UAB, Birmingham, AL, USA, 7.Universitair Ziekenhuis Gent, Ghent, Belgium, 8.Genmab, Princeton, NJ, USA, 9.AbbVie, North Chicago, IL, USA, 10.Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA, 11.Vejle Hospital, Vejle, Denmark)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password